Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catriona A Ford

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Immunology Letters|March 26, 2005
Differential signalling during B-cell maturationMargaret M Harnett, Elad Katz, Catriona A Ford
Advances in Experimental Medicine and Biology|August 26, 2016
Microenvironmental Effects of Cell Death in Malignant DiseaseChristopher D Gregory, Catriona A Ford, Jorine J L P Voss
Blood|September 13, 2003
Bcl-(xL) antagonism of BCR-coupled mitochondrial phospholipase A(2) signaling correlates with protection from apoptosis in WEHI-231 B cellsElad Katz, Caroline Lord, Catriona A Ford, et al.
Cell Death and Differentiation|February 4, 2017
Modulation of macrophage antitumor potential by apoptotic lymphoma cellsJorine J L P Voss, Catriona A Ford, Sofia Petrova, et al.
Nature Communications|January 8, 2026
SOX2 confers tumour permissiveness in a specific skin progenitor populationPatricia P Centeno, Christopher Chester, Georgios Kanellos, et al.
Cancer Research|June 8, 2022
Cyclocreatine Suppresses Creatine Metabolism and Impairs Prostate Cancer ProgressionRachana Patel, Catriona A Ford, Lisa Rodgers, et al.
Blood|September 19, 2008
CX3CL1/fractalkine is released from apoptotic lymphocytes to stimulate macrophage chemotaxisLucy A Truman, Catriona A Ford, Marta Pasikowska, et al.
Nature Communications|January 3, 2024
KRAS allelic imbalance drives tumour initiation yet suppresses metastasis in colorectal cancer in vivoArafath K Najumudeen, Sigrid K Fey, Laura M Millett, et al.
Cancer Research|October 16, 2024
KRAS Loss of Heterozygosity Promotes MAPK-Dependent Pancreatic Ductal Adenocarcinoma Initiation and Induces Therapeutic Sensitivity to MEK InhibitionSigrid K Fey, Arafath K Najumudeen, Dale M Watt, et al.
Cancer Research|December 5, 2024
Targeting the PREX2/RAC1/PI3Kβ Signaling Axis Confers Sensitivity to Clinically Relevant Therapeutic Approaches in MelanomaCatriona A Ford, Dana Koludrovic, Patricia P Centeno, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Immunology Letters|March 26, 2005
Differential signalling during B-cell maturationMargaret M Harnett, Elad Katz, Catriona A Ford
Advances in Experimental Medicine and Biology|August 26, 2016
Microenvironmental Effects of Cell Death in Malignant DiseaseChristopher D Gregory, Catriona A Ford, Jorine J L P Voss
Blood|September 13, 2003
Bcl-(xL) antagonism of BCR-coupled mitochondrial phospholipase A(2) signaling correlates with protection from apoptosis in WEHI-231 B cellsElad Katz, Caroline Lord, Catriona A Ford, et al.
Cell Death and Differentiation|February 4, 2017
Modulation of macrophage antitumor potential by apoptotic lymphoma cellsJorine J L P Voss, Catriona A Ford, Sofia Petrova, et al.
Nature Communications|January 8, 2026
SOX2 confers tumour permissiveness in a specific skin progenitor populationPatricia P Centeno, Christopher Chester, Georgios Kanellos, et al.
Cancer Research|June 8, 2022
Cyclocreatine Suppresses Creatine Metabolism and Impairs Prostate Cancer ProgressionRachana Patel, Catriona A Ford, Lisa Rodgers, et al.
Blood|September 19, 2008
CX3CL1/fractalkine is released from apoptotic lymphocytes to stimulate macrophage chemotaxisLucy A Truman, Catriona A Ford, Marta Pasikowska, et al.
Nature Communications|January 3, 2024
KRAS allelic imbalance drives tumour initiation yet suppresses metastasis in colorectal cancer in vivoArafath K Najumudeen, Sigrid K Fey, Laura M Millett, et al.
Cancer Research|October 16, 2024
KRAS Loss of Heterozygosity Promotes MAPK-Dependent Pancreatic Ductal Adenocarcinoma Initiation and Induces Therapeutic Sensitivity to MEK InhibitionSigrid K Fey, Arafath K Najumudeen, Dale M Watt, et al.
Cancer Research|December 5, 2024
Targeting the PREX2/RAC1/PI3Kβ Signaling Axis Confers Sensitivity to Clinically Relevant Therapeutic Approaches in MelanomaCatriona A Ford, Dana Koludrovic, Patricia P Centeno, et al.
Pageof 2